Joined April 2023
- Tweets 214
- Following 352
- Followers 113
- Likes 95
9 Photos and videos
Glad to see so many friends in top 15. Keep the influence going!
1
4
318
May 14
Remarkable work! Novel prognostic marker in prostrate cancer
Congrats @laurasenamd for publishing the definitive study on IDH1-altered prostate cancers. This is a distinct molecular subtype of PCa with novel therapeutic implications (vorasidenib?). @neerajaiims @VanAllenLab @nikolausschultz europeanurology.com/action/sβ¦
54
May 14
Congrats for bringing this forward. @tompowles1
Very attractive regimen to limit the EV therapy.
May 14
JUST IN: VOLGA Phase III is ( )=>Neoadjuvant Durva EV and adjuvant Durva alone showed EFS & OS benefit. The shorter period of EV is a very attractive option!
@DanaFarber_GU @OncoAlert @OncBrothers @AstraZeneca @tompowles1 @AUC3_Official
38
JKCVHL is the journal that provides open access with no publication fees.
πIncredibly proud of this publication and grateful for the leadership of @salvolarosa @BataiKen @PavlosMsaouel and other contributors who made this important research possible. Our paper is out today with FREE access!
πmdpi.com/2072-6694/18/9/1454
3
93
Apr 18
Inspiring conversations great tips to succeed and collective sponsorship. Letβs aucceed together!
Apr 17
One of our favorite sessions at #IKCSEU26: European Women in RCC & Allies π𧑠today with #AthinaChristopolou @TiansterZhang @drulkav @AlbigesL @ERPlimackMD @lisapic
2
52
Ulka Vaishampayan retweeted
Apr 17
DAY Two of OncoAlert π¨ Coverage of #IKCSEU26
Provider Perceptions of Cure in Renal Cell Cancer Presented by Ms. Dena BattleπΊπΈ of @kcCURE
RCC specialists demonstrate notable hesitancy in using the term βcure,β even in clinical contexts where long-term outcomes may justify it. This reluctance reflects not only clinical uncertainty but also parallels similar reservations among patients. The absence of a standardized definition contributes to inconsistent communication, potentially affecting expectations and decision-making. Establishing clearer, consensus-driven terminology around βcureβ in RCC could enhance transparency, improve physicianβpatient alignment, and support more informed shared decision-making. Addressing this linguistic and conceptual gap may ultimately strengthen trust and facilitate more meaningful discussions about prognosis and treatment goals in renal cell carcinoma care. #KidneyCancer
@KidneyCancer Jean-Christophe Bernhard @univbordeaux @AlbigesL @gustaveroussy @TiansterZhang @Dr_SabyGeorge @ZakhariaYousef @ERPlimackMD @Ric_Campi @DrIacovelli @RebuzziSara @weoncologists @GEVaughan1 @salvolarosa @DrYukselUrun #KidneyCancer @daniyal_jafree @EJonasch @IKCCorg @sophiemerrick1 @BarbaraJereczek @ESTRO_RT @ZakhariaYousef @kuraoncology @Selcuk__Erdem @drulkav @RCCadvocate
11
15
4,551
Apr 16
Kicking off the IKCS Europe meeting with Think tank. Exciting discussions have started.
Apr 16
Always a dynamic discussion during KCA Think Tank meetings where many of our most impactful programs and moonshot initiatives have sparked!
Thanks to our #IKCSEU26 TT presenters #LarsLund @grantissimus @srossi725 @MichaelStaehler @RCCadvocate #axelbex
@salvolarosa @GEVaughan1
2
55
Ulka Vaishampayan retweeted
Mar 28
We joined @FOX26Houston this week to talk kidney cancer π§‘
KCAβs Gretchen Vaughan and patient advocate Josh Silva shared Joshβs journey, key symptoms, and how to support the KCA 81K Challenge β amplifying patient voices and raising awareness where it matters most!
2
14
509
Mar 24
Grateful to join this wonderful mtg @PGrivasMDPhD and @chandlerpark and be a part of this panel.
Albert, great discussion with a powerhouse prostate cancer panelβDr. Maha Hussain, Dr. Sandy Srinivas, Dr. Dan Petrylak, Dr. Ulka Vaishampayan, and Dr. Ben Maughan π
We learned so much from your case discussion at #MatosGU26. This is how we all get better. @AJangMD @PGrivasMDPhD @mecmededucation π‘
π₯ Loved this moment. Great job Albert!
#Oncology #MedEd #ProstateCancer
@DanielPetrylak @sandysrimd @DrVaishampayan @maughanonc @oncodaily @urotoday @Larvol
54
Mar 22
#MaTOS meeting
Mar 21
Awesome talk by @MVossMD on non clear cell RCC covering different histology types: evolving landscape but need specific trials for each histology!
@ZakhariaYousef @CParkMD @EddieSantosMD @LuisRaezMD @mecmededucation @ADESAIONCMD @sandysrimd @ChadTangMD @HHammersMD @JadChahoud
1
66
Mar 12
Great job and Agree @JoshMeeks
Mar 11
We, @DanaFarber_GU, and @MGBUrology enjoyed very much hosting @JoshMeeks from @NM_Urology βJosh is a super star surgeon-scientist who is pushing the envelope in bladder cancer with a focus on epigenetics! He also β€οΈ @RedSox !
2
134
Biofront opening soon. #rogelcancercenter #swog
Weβre so excited to have you @LauraEsfeller and @swog team @montypal @DrVaishampayan pushing this important study forward - very soon (April 1st) close to you! π«΅ #GU26
124
Ulka Vaishampayan retweeted
Weβre so excited to have you @LauraEsfeller and @swog team @montypal @DrVaishampayan pushing this important study forward - very soon (April 1st) close to you! π«΅ #GU26
1
1
229
Pls activate Swog 2419 the BIOFRONT trial. First large randomized trial testing combo of probiotic with immune therapy ( Ipi and nivo or Cabo and nivo or Len and pembro) in Frontline RCC @ esfeller
Mar 1
Finally, a clinical trial Iβve been working on for 2 years w/ @PBarataMD @drulkav @montypal @BrianShuch & many others @SWOG opens for enrollment very, very soon, and I couldnβt be more excited. S2419 (BIOFRONT) will be the first SWOG trial and the first phase III trial anywhere
114
Ulka Vaishampayan retweeted
π #GU26 is in the books for team KCA! Ahead of #KidneyCancerAwarenessMonth, amazing to see the work advocates, researchers, and more are doing together to drive #kidneycancer science forward - proud to contribute to the efforts π§‘
So much for patients to be hopeful about!
5
35
1,983
Feb 22
Great work with the contemporary guidelines @shilpaonc
Great to be part of this group. IBCG Consensus for optimal management of muscle-invasive bladder cancer @shilpaonc @UroDocAsh
1
2
347
Commendable to help define response and continue advancement in MIBC
Feb 6
Happy to share a vision with my friend @UroDocAsh on our continuing efforts to optimize treatments and outcomes for patients with MIBC #bladdercancer #clinicalresearch @SanRaffaeleMI @MyUniSR @urotoday @IBCG_BladderCA @OncoAlert @ASCO #DailyNews
Developing Clinical Complete Response Definitions for Muscle-Invasive Bladder Cancer dailynews.ascopubs.org/do/deβ¦
45
Jan 22
Loving the spirited discussions of controversies we face daily as we consider therapies for our patients. #AUC3 meeting
@DrRanaMcKay @DrChoueiri
Jan 22
Fantastic #AUC3 meeting organised by @DrChoueiri @DrRanaMcKay @montypal @DrRosenbergMSK covering spectrum of urinary tract & renal cell carcinomas. Amazing speakers, discussion, camaraderie! @ChadTangMD @brian_rini @tompowles1 @shilpaonc @AndreaNecchi @apolo_andrea @OncoAlert
2
3
209